Trial intelligence / Profile preview

Colloids vs Crystalloids on Heart Mechanics

NCT06900972Phase 3Enrolling by invitation

Sponsor
Université de Monastir
Start
Apr 2025
Primary completion
Aug 2025
Modality
Recombinant Proteins and Enzymes, Drug Delivery Systems
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of gelatin in hypovolemia (2 arms), sponsored by Université de Monastir. Primary endpoint: Left ventricular longitudinal strain, left ventricular torsion, left atrial strain, right ventricular free wall strain at 1 day. Started Apr 2025; status: enrolling by invitation.

02

Drugs

gelatin
03

Conditions

hypovolemia

Beyond the preview

Go deeper on NCT06900972.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06900972.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call